ClinicalTrials.gg
Sign In

Hypertriglyceridemia clinical trials

The registry lists 324 studies for Hypertriglyceridemia across more than 10 countries. 38 are recruiting or about to start. 198 of them are mainly about Hypertriglyceridemia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Hypertriglyceridemia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
220
Recruiting
22
Status unknown
20
Terminated
18
Active, not recruiting
16
Not yet recruiting
15

Phase

Phase 2
81
Phase 3
62
Phase 1
38
Phase 4
37
Early Phase 1
4

Where

United States
150
Canada
51
China
26
France
18
Germany
17
Hungary
17

Who runs them

AstraZeneca (12) · Ionis Pharmaceuticals, Inc. (10) · Arrowhead Pharmaceuticals (8) · GlaxoSmithKline (7) · Essentialis, Inc. (6) · Abbott (5) · Novartis Pharmaceuticals (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5)

What is being tested here

Drugs under test in Hypertriglyceridemia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
DR10624425
MAR001203
CS-121202
Eicosapentaenoic acid ethyl ester159
Plozasiran157
Eicosapentaenoic Acid124
Docosahexaenoic Acids103
Semaglutide101
Pemafibrate101
Solbinsiran101

Drug classes tested here Statins 7

Coming up

8phase 3 studies under way
21studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 22 Hypertriglyceridemia studies recruiting now, 9 (41%) set no upper age limit and 12 (55%) stop at 75 or younger. 2 (9%) take children under 18. 2 (9%) are for women only and 0 (0%) for men only; 4 (18%) take healthy volunteers.

Recruiting studies that take each age, of 22
AgeWomenMen
102 (9%)1 (5%)
1820 (91%)19 (86%)
3022 (100%)20 (91%)
4022 (100%)20 (91%)
5021 (95%)20 (91%)
6520 (91%)19 (86%)
7515 (68%)14 (64%)
8510 (45%)9 (41%)

Across all 324 studies, recruiting or not: 56% stop at 75 or younger and 26% at 65; 11% take children; 2% are for women only and 2% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hypertriglyceridemia studies take

Of 29 phase 3 interventional studies under Hypertriglyceridemia, half reached primary completion within 24 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 120 mo16–28 · 15 studies——
Phase 221 mo10–40 · 23 studies——
Phase 324 mo18–31 · 29 studies24 mo18–31 · 28 studies—
Interventional, no phase23 mo7–33 · 45 studies—23 mo7–39 · 42 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Stopped1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 324. Browse all 324 → or search them.